FangXiang Wu is a full professor in the College of Engineering, Department of Computer Science at the University of Saskatchewan, Canada. Dr. Wu received his B. Sc. degree and M. Sc. degree in Applied Mathematics from Dalian University of Technology, Dalian, China in 1990 and 1993, respectively. His first Ph.D. was in Control Theory and Its Applications from Northwestern Polytechnical University, Xi’an, China, in 1998, and the second Ph.D. was in Bioinformatics and Systems Biology from University of Saskatchewan, Saskatoon, Canada, in 2004. He worked as a postdoctoral fellow with Laval University Medical Research Center, Quebec City, Quebec.

Zhu-Hong You (M’14) received his B.E. degree in Electronic Information Science and Engineering from Hunan Normal University, Changsha, China. He obtained his Ph.D. degree in control science and engineering from University of Science & Technology of China (USTC), Hefei, China, in 2010. He was a postdoctoral research fellow respectively in Tongji University, Shanghai, China and in Hong Kong Polytechnic University. In July 2015, he entered into China University of Mining and Technology as Professor. In 2016, he joined the Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences as the Recipient of “Hundred Talents Program of CAS”.

Ravinder Abrol is an Assistant Professor of Biochemistry in the Department of Chemistry and Biochemistry at California State University Northridge, California. He received his PhD in Chemistry from California Institute of Technology. He has been applying chemical and biophysical principles to understand the role of protein function in signaling and to elucidate the molecular basis of specific diseases. He is developing computational methods to predict the structure and functional activity of GPCRs, to predict protein-protein interactions, and to rationally design drugs with minimal side-effects. The computational studies are tightly coupled to experiments to generate and test hypotheses about the role of specific proteins and mutations in the normal and disease state of cells.

Ruedi Aebersold is Professor of Systems Biology at the Institute of Molecular Systems Biology (IMSB) in ETH Zurich. His team uses quantitative mass spectrometry to differentiate cells in different states, and to systematically study how cells respond to external stimuli. This is expected to lead to new diagnostic markers for disease and to a more complete understanding of the biochemical processes that control and constitute cell physiology. Ruedi Aebersold is a pioneer in the fields of proteomics and systems biology and has developed a series of methods that have found wide application in analytical protein chemistry.

N. Leigh Anderson, PhD is a Founder and CEO of SISCAPA Assay Technologies, (www.SISCAPA.com). SISCAPA aims to improve clinical diagnostics with sensitive, specific peptide-level assays for protein biomarkers. Dr. Anderson was previously CSO at Large Scale Biology Corporation, which he co-founded in 1985, and has served as a director of three public technology companies including Dade Behring, a global diagnostics company. Dr. Anderson obtained a B.A. in Physics from Yale and a Ph.D. in Molecular Biology from Cambridge University (England), has published 170 papers, been granted 40 US Patents, and was awarded the 2009 HUPO Distinguished Achievement Award in Proteomic Science.

Professor of Bioinformatics and Director of the Department of Human Protein Science at the University of Geneva, Amos Bairoch is head of the CALIPHO group of the SIB - Swiss Institute of Bioinformatics. Until June 2009, Amos headed the Swiss-Prot group which develops the UniProtKB/Swiss-Prot knowledgebase which he created in 1986 as well as the PROSITE and ENZYME databases. He was also co-responsible for the development of ExPASy, the world’s first website dedicated to protein molecular biology. Amos Bairoch’s main work lies in the field of protein sequence analysis and the development of databases and software tools for this purpose. Currently his main activities are focused on the development of neXtProt, a web knowledge platform on human proteins and of the Cellosaurus, a cell line knowledgebase. Amos Bairoch has been awarded several distinctions, among which the European Latsis Prize, the Otto Naegeli Prize and the HUPO Distinguished Achievement Award. He is an ISCB Fellow.

Dr. Banerrji is a Biochemist trained at The Scripps Research Institute, USA and the Max-Planck Institute for Biophysical Chemistry, Germany. He is currently, an Associate Professor of Biochemistry; and with clinical research focusing on lipid and lipoprotein metabolism, metabolomics, toxinomics (especially concerning arthropod and reptilian venom), coagulation biochemistry and anticoagulants; is involved in medical education, curriculum and course-design and delineation of student assessment policies. He is the lead author on several key publications concerning lipid metabolism and anticoagulants and has two international patents.

Dr. Marilena Budroni obtained her Degree in Agricultural Sciences and PhD in Microbial Biotechnologies at the University of Sassari; Postgraduate in Viticulture and Oenology. She is an Associate Professor in Microbiology, at the University of Sassari. Dr. Budroni Research activities focused on the genetic and physiology of microorganisms of biotechnological interest, more recently focused on brewer yeast strains. Author and co-author of 120 scientific papers including 50 peer reviewed articles on international journals indexed by Scopus and WoS, H index 16. PI of national projects.

Fabrizio Ceciliani, DVM, PhD, is an Associated Professor of Veterinary Pathology at the University of Milano. He graduated in Veterinary Medicine at the University of Milano. In 1994 gained a PhD in Biochemistry and in 1995 gained a post doc position in Molecular Biology at the University of Milano. Current interests include the immune response in white blood cells and the involvement of adipose tissue in innate immune response. He teaches Molecular Pathology at the School of Veterinary Biotechnology of the University of Milano.

Dr. A. Chambery is the Chair in Biochemistry at the Pharmacy Course, Second University of Naples (SUN) and Head of the “Mass spectrometry and Proteomics” lab at the DiSTABiF Department (SUN). Dr. Chambery has a long-standing experience in the field of biochemistry, proteomics and mass spectrometry. Recently, Dr. Chambery devoted much research time to investigate the molecular profile of cellular secretomes with the aim of deciphering the molecular crosstalk between cells and tissues under physiological and pathological conditions. Dr. Chambery has authored more than 100 manuscripts, in ISI peer-reviewed journals.

Xing Chen Professor of School of Information and Control Engineering, China University of Mining and Technology and founding director of Institute of Bioinformatics, China University of Mining and Technology. He serves as associate editor, editorial board member or lead guest editor for academic journals such as BMC Systems Biology, Scientific Reports, Current Protein & Peptide Science, Frontiers in Microbiology, Current Medicinal Chemistry, International Journal of Molecular Sciences, Current Topics in Medicinal Chemistry. In recent years, he published 83 SCI papers in the journals such as Bioinformatics, PLOS Computational Biology, Nucleic Acids Research, Briefings in Bioinformatics, Cell Death & Disease.

Dr. Kuo-Chen Chou is the founder of Gordon Life Science Institute, the first Internet Research Institute ever established in the world. He is also a Distinguished High Impact Professor and Advisory Professor of several Universities. In 2009 he was honored by “Web of Science” as the “The Scientist with the Most Hot Papers (2007-2008) in the World”. According to “Google Scholar Citations”, as of Jan 2018, Professor Chou has published over 580 papers with H-index of 131. Since 2014, he has been every year selected by “Thompson Reuters”/”Clarivate Analytics” as a “Highly Cited Researcher”, listed in the “World’s Most Influential Minds”. In 2017, he was named as one of the 21 world’s "Brightest Stars” in science.

Celso Cunha has a PhD in Biology from Lisbon University. He leads a research group whose main interests are related to the molecular and celular biology of Hepatitis B and D viruses. Celso Cunha is author of more than fourty publications in peer-reviewed journals. He has and extensive experience of revieweing manuscripts for several journals and project evaluation for different funding agencies. Celso Cunha is currently Associate Professor of Microbiology in the Institute of Hygiene and Tropical Medicine, NOVA University, Lisbon where also coordinates a Master program in biomedical sciences.

Dr. D’Auria is the Director of the Institute of Food Science, CNR, Avellino, and an Associated Professor at INRS, Laval, Canada. He also heads the Laboratory of Protein Biophysics and Biosensor Development at ISA-CNR, Avellino, Italy. The main interests of Dr. D’Auria Lab are focused on the design and realization of advanced bio/sensors for safety and security. Dr. D’Auria has authotred more than 200 publications on international journals and several national and international patetnts.

Dr. Norelle Daly obtained a Doctorate in Biochemistry from The University of Queensland, Brisbane. Her research involves the use of NMR spectroscopy to study peptides with therapeutic potential, and she has been centrally involved in determining the structures of more than 50 cystine-rich peptides including peptides isolated from plants, cone-snails, bacteria, spiders and frogs. She has authored more than 150 manuscripts and is an inventor on three patents. Currently she is a Professor at James Cook University, Cairns where her research focuses on peptides involved in anti-inflammatory diseases and wound healing.

I graduated Ege University Medical Faculty, Turkey, in 1986, I took Physiology Specialty in Ataturk University of Turkey. I worked as professor in Ataturk, Fatih and Turgut Ozal Universities in Turkey. I became emeritus in Turkey. Now, I am working in Nile University of Nigeria and Head of Physiology Department.

Dr. Sebastien Dutertre was awarded his PhD from the University of Queensland (Australia) in 2006. He then obtained an EMBO postdoctoral fellowship to work at the Max-Planck Institute for Brain Research (Germany) in the laboratory of Professor Heinrich Betz on the structure-function of ion channels (2006-2007). Next, he joined Atheris laboratories (Switzerland) to work on a European funded project dedicated to the discovery and development of venom peptides as therapeutics. In 2010, he was awarded a UQ postdoctoral fellowship to join Prof. Richard Lewis’ groups at the Institute for Molecular Bioscience, and since 2014, he holds a permanent position at the CNRS, University of Montpellier (France) where he developed an integrated approach to accelerate the discovery of novel peptides from animal venoms.

Dr. Emmert-Buck is a physician-scientist who retired in 2014 from his post of over twenty years as an NIH principal investigator to launch the Avoneaux Medical Institute. His accomplishments at the NIH include publishing over 200 research manuscripts and book chapters and being an inventor on 20 patents. In addition to his academic work, Dr. EmmertBuck has extensive entrepreneurial experience, with inventions used as the founding technology for five startup companies. The goal of the Avoneaux Medical Institute is to work at the interface of academia and industry to develop new technologies and clinical interventions that benefit the public and patients.

Prof. Franca Fraternali received her PhD in Physical Chemistry from the University of Naples, spending part of the PhD at the Polytechnic of Zurich (ETH), She later worked as post-doctoral fellow at the Institute Pasteur in Strasbourg and at the European Molecular Laboratories in Heidelberg (EMBL). In 2000 she became staff scientist at the Mathematical Biology Division of the National Institute for Medical Research in London. Since 2005 she has established her own group at King’s College within the Randall Division. In 2012 she was awarded the Chair of Bioinformatics and Computational Biology. She has published more than 100 papers on specialised journals and she is an active member of the Royal Society of Chemistry and a Fellow the Royal Society of Biology.

Dr. Sean R. Gallagher is currently the Vice President and Chief Technology Officer at Analytik Jena USA and has 30 years of experience in the Life Sciences industry, with an emphasis on instrumentation and applications development. After completing his PhD in plant biology in 1985 from the University of California, Riverside, he held a post-doctoral scholar position at Stanford University before moving into industry. Prior to Analytik Jena, Dr. Gallagher held executive management positions at Hoefer Scientific Instruments, Hoefer Pharmacia Biotech, Motorola, Ionian Technologies, and UVP. At Motorola, he was a founding member of Motorola Life Sciences, focusing on microfluidics and microarray platform development. Dr. Gallagher left Motorola to become President and CEO of Ionian Technologies, the first company spun out of Keck Graduate Institute before moving to his current position as VP and CTO at Analytik Jena USA where he heads up R&D for imaging and laboratory products. A critical component of his commercial activity is the support of Keck Graduate Institute students through internships and joint commercial - academic partnerships focusing on technology and marketing areas of interest.

Dr. Ge is a Professor of Institute of Hydrobiology (IHB), Chinese Academy of Sciences (CAS). He is the awardees of Hundred Talents Program of CAS, Leader of Functional Proteomics Group of IHB. His group is using state-of-the-art mass spectrometric methods for identification of proteins and for characterizing post-translational modifications in signal transduction pathways and in the analysis human and several different organisms. They are using different techniques to quantitate levels of protein as well as post-translational modifications. They are also developing computational methods that allow us to extract annotated information from existing databases including genomic databases while performing searches using MS-derived data.

Dr. Stefania Gonfloni received a Degree in Biology (LAUREA in Scienze Biologiche, University of Rome "Tor Vergata" Summa cum laude) in 1991. She did Masters in Biophysics (International School for Advanced Studies/ISAS Trieste Italy) in 1993. Later, she did PhD in Biophysics (International School for Advanced Studies/ISAS Trieste, Italy) in 1995. Since 2001, Dr. Gonfloni is an Assistant Professor, Dept. Biology, University of Rome.

David R. Goodlett is Professor of Pharmaceutical Sciences at the University of Maryland. He was previously the first Director of Proteomics at the Institute for System Biology; a Professor at the University of Washington; and a Finland Distinguished Professor at the University of Turku; https://www.youtube.com/watch?v=jfOOMNJivvY. His scientific interests have resulted in > 200 publications and lectures as well as a half-dozen patents / applications that revolve around solving structure function relationships in proteins and immunoreactive glycolipids; goodlettlab.org. He is co-founder of Deurion a Seattle, WA company focused on ion sources for mass spectrometry and Pataigin a Baltimore, MD startup focused bacterial diagnostics.

Kyungsook Han is a professor at the Department of Computer Science and Engineering, Inha University, Incheon, Korea. She received a BS cum laude from Seoul National University in 1983, an MS cum laude in Computer Science from Korea Advanced Institute of Science and Technology (KAIST) in 1985, another MS in Computer Science from the University of Minnesota at Minneapolis, USA in 1989, and a PhD in Computer Science from Rutgers University, USA in 1994. Her research areas include bioinformatics, visualization, and learning.

Dr. Rasmus Hartmann-Petersen is an associate professor at the Department of Biology, University of Copenhagen, Denmark. He has nearly 20 years of experience in research on protein misfolding, degradation and the ubiquitin-proteasome system. In his research Dr. Hartmann-Petersen utilizes a combination of genetics, cell biology and proteomics techniques on yeast and mammalian cells.

Dr. Herman obtained his doctorate (Ph.D.) in biophysics from the Charles University, Czech Republic. Currently Dr. Herman is a full professor of molecular and biological structures at the Charles University, Faculty of Mathematics and Physics in Prague. He has published more than 90 scientific publications and is a named inventor of 6 issued U.S. and Czech patents.

Hubert Hondermarck is Professor of medical biochemistry at the University of Newcastle (Australia). Hubert has over 25 years of experience with cancer proteomics, starting with 2D electrophoresis and up to now with high-resolution mass spectrometry analyses. He received a PhD in neurobiochemistry from the University of Lille (France) and was a postdoctoral fellow at the University of California Irvine where he worked on deciphering neuronal cell signaling by using proteomics. He was first to discover the role of neurotrophic growth factors in breast cancer and was head of a cancer research unit at the French National Institute of Health. Hubert was also the Chair of the French proteomics society and a member of the HUPO board of directors. Hubert current research involves proteomics and focuses on studying the crosstalk between the nervous system and cancer, with the objective of translating this basic knowledge into innovative new strategies for cancer management.

Rod Hubbard has been an academic at the University of York, UK for over 35 years where his research interests continue in the development and application of methods for the study and exploitation of protein structure. In the 1980s and early 1990s he developed molecular graphics and modelling methods commercialised by MSI / Accelrys. During the 1990s he helped to build and directed the York Structural Biology Laboratory, determining the structure of many important classes of proteins. During this time he developed interests in the study of protein- ligand interactions and the application of experimental and computational methods which included working with various pharmaceutical and biotechnology companies. He helped to establish the drug discovery company now known as Vernalis (R&D) and since 2001 has spent varying amounts of his time with Vernalis, establishing a leading profile in fragment based drug discovery. Currently he splits his time between York (as Professor of Chemistry) and Vernalis and in addition is a member of various boards for the Research Counclis and consults for pharmaceutical companies around the world.

Dr. Christian W. Huck currently holds a position of a full professor for analytical chemistry at Leopold-Franzens University of Innsbruck, Austria. Currently, Prof. Huck is also guest professor at Kwansei Gakuin University (Sanda, Hyogo, Japan). He has published more than 200 scientific publications describing new analytical attempts in vibrational spectroscopy (different modes of infrared and Raman) and separation science including mass spectrometry (LC, SPE, CE, CEC, -MS, MALDI) and is a named inventor of 14 issued international patents. Prof. Huck has received several international awards (e.g., Buechi, Euregio, Swarovski etc).

Esther Imperlini is a post-doctoral research associate at IRCCS SDN of Naples, Italy and Adjunct Professor at Department of Movement Sciences and Wellness, University of Naples ‘‘Parthenope’’, Italy. She obtained her PhD in Chemical Sciences from the University of Naples ‘‘Federico II’’; her Residency in Clinical Biochemistry from the University of Naples ‘‘Federico II’’; and her post-doctoral training from CEINGE-Biotecnologie Avanzate s.c.a r.l. of Naples, Italy. She currently focuses on the physiopathological processes in biomedical fields through the most advanced methods in proteomics.

Daniel Jay is a Professor of Developmental, Molecular and Chemical Biology at Tufts University School of Medicine. He developed Chromophore Assisted Light Inactivation (CALI) of Protein Function and applied this technology functional proteomic studies in neurodevelopment and cancer biology. He was named a Proteome Pioneer by the online journal ProteomMonitor.

Thierry Jouenne is research director at the National Centre of Scientific Research (CNRS) and head of the laboratory of “Polymers, Biopolymers, Surfaces” (PBS, UMR CNRS 6270, University of Rouen, France, http://pbs.labos.univ-rouen.fr ). Since 2003, he is scientific director of the proteomic PISSARO facility in Rouen (http://plateforme-proteomique.crihan.fr) He was awarded a PhD in Cellular Biology in 1984 and in Biophysicochemistry in 1989. He is co-author of more than 195 peer-reviewed publications (HF, 29) and is co-inventor of four patents. His main research interest lies in proteomics of biofilm organisms and in the development of innovative antibiofilm surfaces.

Dr. Kim received B.S. and M.S. degrees in Mechanical Engineering from Seoul National University, Korea in 1997 and 1999, respectively, and Ph.D. degree from the Johns Hopkins University, USA in 2004. He had been an Assistant Professor in the Department of Mechanical and Industrial Engineering at University of Massachusetts, Amherst from 2004 to 2008. In 2008, he joined Sungkyungkwan University, where he is currently a Professor and Director of Computational Bioengineering Laboratory in School of Mechanical Engineering. His research interests are focused on, but not limited to, Computational Structural Biology, Multiscale and Multiphysics Simulation, and Computational Mechanics. He has published more than 230 papers including 70 journal papers and received Young Investigator Award from the Asian-Pacific Association for Computational Mechanics (APACM) in 2013.

Karl-Wilhelm Koch is full Professor of Biochemistry at the Carl-von-Ossietzky University Oldenburg, Germany. He studied Chemistry and Biochemistry at the University Münster (Germany) and obtained a doctorate (Dr. rer. nat) from the University of Osnabrück in Germany. He has co-authored more than 120 publications. His research topics are molecular and cellular processes of vertebrate phototransduction, structure-functions studies on guanylate cyclases, calcium-binding proteins and receptor molecules.

Setsuko Komatsu is a Chief of Field Omics Research Unit at National Institute of Crop Science and a Professor at University of Tsukuba, Japan. She employed at Meiji Pharmaceutical University and then also Medicine at Keio University, school of Medicine. Since 1990, she started working on plant proteomics using protein sequencer and mass spectrometry by a present official position. Her main research interests are within the field of crop proteomics, biochemistry and molecular biology with a special focus on signal transduction in cell. She has authored more than 300 manuscripts on plant omics research.

Dr. Sotirios Koutsopoulos is a researcher in the Center for Biomedical Engineering at Massachusetts Institute of Technology. Dr. Koutsopoulos’ research is focusing on the design of novel peptides sequences with many applications including membrane protein purification and stabilization, tissue engineering, organ regeneration, drug delivery, neurodegenerative diseases, and immunoengineering. He has consulted with many biotech companies, holds three patents on the applications of self-assembling peptides, serves as member of the Editorial Boards in two journals and has published over 60 research articles and book chapters.

Professor Kurpisz has been Head of Department of Reproductive Biology and Stem Cells, Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland. He graduated Poznan Medical University. Then he was promoted as MD in Immunology and Ph.D. in Genetics, since 1996 a full professor. He performed professional training in UK, USA, Japan and Germany. His clinical practice includes reproductive immunology, infertility, andrology and anti-aging. His experimental therapy is dedicated to regenerative medicine, mainly stem cell implementation. He has published over 390 papers, half referred in PubMed, successfully sought 67 grants, supervised 13 doctorates and 29 masters. He is a member of board of 8 international journals and recipient of 20 professional awards. He also received an Honorary Doctorate (honoris causa) from Lviv Medical University as well as the title of “Man of the Year 2010” was granted to him from American Biographical Institute.

Claire Lemaire is biochemist specialized in membrane proteins at the Institute for Integrative Biology of the Cell (I2BC) in Gif-sur-Yvette (France). She began her career in the photosynthesis field on the assembly and regulation of photosynthetic complexes (I.B.P.C., Paris). She then joined the C.N.R.S. (French National Center for Scientific Research) where she acquired a solid expertise in the respiratory complexes. These last years, she has developed a research project with her group focusing on the regulation of mitochondrial proteins by phosphorylation combining molecular biology, biochemistry and mass spectrometry.

Dr. Lovas obtained his formal training in chemistry in Hungary at the József Attila University and the Biological Research Center of the Hungarian Academy of Sciences, Szeged. In 1990, he joined Creighton University where he is a Professor of Biomedical Sciences. His research deals with conformation-biological activity relationships of polypeptides and description of solution structure of polypeptides by molecular dynamics simulations, ab initio quantum chemical calculations and chiroptical spectroscopy. He has published over 140 scientific publications.

Dr. Martins is a researcher on bioinformatics at Embrapa since 2001. She has nearly 20 years of experience in the research fields of Biochemistry, Bioinformatics and protein characterization. Previously Dr. Martins worked at Rothamsted Research (2012) as an invited fellow and at Université Henri Poincaré (2000), as a post-doc. During her career, she holds a PhD in Biochemistry and Immunology from the Universidade Federal de Minas Gerais (1998), a master's degree in Molecular Biology from the University of Brasilia (1993) and a degree in Biological Sciences from University of Brasília (1989). Dr. Martins has also authored more than 50 manuscripts, 4 patents and co-edited “Talking About Computing and Genomics”. During her research she has gained experience in Genomics and pathogenomics, with an emphasis on functional and structural bioinformatics, acting on the following topics: genomics bioinformatics, genomic analysis, annotation and biotechnology. Additionally, has leadership in networking projects applied to agriculture and participates in workshops management and students orientation.

Dr Melroses PhD studies in Edinburgh, Scotland (1978-82) employed fungal taxonomy, mycology, immunology and biochemical techniques to isolate and characterise cereal and fungal araboninoxylanases. He became a postdoctoral Research Fellow in Musculoskeletal disorders at The University of Sydney, Australia (1983-2113) where he investigated tensional and weight bearing musculoskeletal tissues including intervertebral disc, articular cartilage, meniscus, and tendon in health and disease and developed therapeutic stem cell technology for their repair. Dr Melrose is currently Honorary Senior Research Associate at the University of Sydney and Adjunct Professor Graduate School of Biomedical Engineering, University of New South Wales, Sydney, Australia. He has published 132 scientific papers and 14 book chapters and has consulted on Welcome Foundation (UK), Inserm (France), Netherlands Asthma Foundation, BIRAX Israel-UK Collaborative grants, Hong Kong Regional Grants Council, NHMRC Project and Senior Fellowship Grant Applications. Dr Melrose has been Associate Editor Eur Spine J since 2007 and is an Editorial board member of The Open Orthopaedics Journal (2008-current).

Associate Professor Molloy is Director of the Australian Proteome Analysis Facility, Macquarie University, Sydney, Australia and has over 20 years expertise in the application of proteomics and mass spectrometry for biomedical research. Molloy was a research fellow at the University of Michigan Medical School and a Senior Principal Scientist at Pfizer Inc., using proteomics for drug discovery. He has over 100 publications where his research is focused on new method development and applications of proteomics in translational cancer research.

Dr. Nakazawa is Professor of Chemistry in Nara Women’s University. He majored chemistry as undergraduate student in Osaka University, completed his Ph.D study on the chemical modification and isotope labeling of proteins at Institute for Protein Research, Osaka University. Besides his interest in structure-function relationship of proteins, Dr. Nakazawa is now devoted to developing protein archaeology, to which he applied protein chemistry and proteomics based on mass spectrometry.

Dr Gianna Palmieri is Researcher of the Institute of Biosciences and Bioresources at National Council of Research (IBBR-CNR). She got her degree in Chemistry (1989) and a Specialization in Advanced Biotechnology (1994) at University of Naples. She attended (1990-1991) the Department of Chemistry at MIT, Boston (USA). She is a senior group leader and her research focus on structure/function relationship of proteins and enzymes and their biotechnological applications. She is scientific responsible and/or coordinator of several European and Regional projects. She is reviewer of international journals and she has authored 50 publications on international peer-reviewed journals receiving over 2500 citations.

Dr. Konstantinos Papadimitriou received his B.Sc./M.Sc. in Food Science and Technology from the Agricultural University of Athens (AUA, 1998). He pursued an additional M.Sc. degree in Genetic Manipulation and Molecular Biology from the University of Sussex (2000). He received his PhD degree in Food Microbiology with a specialization in Dairy Microbiology from AUA (2006). He has worked in different research projects gaining extensive postdoctoral experience of more than ten years in the Technological properties, the Physiology, the Genetics and the Genomics of lactic acid bacteria. He is currently involved in the Metagenomics of fermented foods.

Dr. David Sánchez Peñaranda obtained his Ph.D. degree in 2008, with focus on the evaluation and cryoconservation of gametes, from Technical University of Valencia, Valencia, Spain. Dr. Peñaranda is currently working in the department of Higher Technical School of Agricultural Engineers at Technical University of Valencia. His skills and expertise mainly lie in the subject areas of Animal Production, Animal Physiology, Animal Genetics, Semen Analysis, etc. Dr. Peñaranda, as an author/co-author, has published more than 55 articles in various journals, having over 690 total citations.

Animesh Ray is a systems biologist, with current research interests in the molecular mechanisms in cancer and Huntington’s disease. He is professor of systems biology at Keck Graduate Institute in Claremont, California. He holds a PhD in molecular genetics, was a research fellow at the University of Oregon’s Institute of Molecular Biology, at Massachusetts Institute of Technology in Cambridge, MA, and was an associate professor at University of Rochester in New York. He was a visiting professor at University of California at San Diego, Institute for Systems Biology in Seattle, and is currently a visiting faculty at California Institute of Technology, Pasadena.

Dr. Ruvo graduated in Chemistry at the University of Naples in 1991. He spent the first 10 years of his career as industrial researcher (Tecnogen, Italy), working as head of the protein and peptide laboratory and contributing at the development of several bioactive peptides. In 2002, he joined the Institute of Biostructures and Bioimaging of the National Research Council (IBB-CNR) in Naples, working as senior scientist and leading several projects focused on the development of new bioactive peptides and monoclonal antibodies against targets with a role in cancers development. Among the others, he has developed peptides modulating the activity of PlGF, Cripto, and Gadd45β and mAbs against Nodal, the E2 protein of HCV and Cripto. He is also the scientific founder of Kesios Therapeutics Ltd (London). He is author of about 100 papers and inventor of >10 patents.

Dr. Kazuyasu Sakaguchi received his Ph.D. in Biochemistry at Kyushu University, Japan in 1989. In 1989, he joined a group of Dr. Ettore Appella at National Institutes of Health, National Cancer Institute, USA. From 1989 to 1999, he was a postdoctoral fellow, associate fellow, and staff scientist at the NIH. He moved to Kyushu University as an Associate Professor in 1999. In 2003, he joined to the Department of Chemistry, Hokkaido University as a full Professor. His recent research has focused on structure and function of tumor suppressor protein p53, especially the tetramer formation of p53, and function and regulation of oncogenic protein phosphatase PPM1D. His research interest also includes development of functionalized nanowire based on self-assembly of modified amyloid peptides. Dr. Sakaguchi has published more than 130 articles (total citations are over 13,000 and h-index is 52).

Salvatore Sechi received his Doctoral degree in biology/biochemistry from the University of Padua in Italy in 1987. He joined the National Institutes of Health as a Fogarty fellow in 1990. While a Fogarty fellow he was trained in protein chemistry; he contributed to the cloning of several novel genes and patented several unique methods for protein sequence analysis. In 1995, he joined, as research associate, the Laboratory of Mass Spectrometry and Gaseous Ion Chemistry at The Rockefeller University, where he developed several novel methods for protein characterization and quantification by mass spectrometry. In 1998/99 he worked as a principal investigator at Dupont and was appointed as a visiting professor at the University of Padua. In 2000 Dr. Sechi was appointed head of the mass spectrometry unit at the National Institute on Aging, and in 2001 he accepted his current position as Program Director in Proteomics and Systems Biology at the National Institutes of Diabetes and Digestive and Kidney Diseases. In his current role, Dr. Sechi has been managing several projects that are at the forefront in the application of proteomics to human diseases.

Dr. Shi is an Associate Research Professor in the Center for Genetic Medicine Research and the Department of Integrative Systems Biology, Gorge Washington University. His main research area is on the structure-function relationships of nitrogen metabolism-related enzymes. Research in Dr. Shi’s laboratory integrates the tools of x-ray crystallography, protein biochemistry and molecular biology into an analysis of the role of enzymes in nitrogen metabolism. Dr. Shi holds Ph.D. in biophysics from University of Sydney, Australia. He has authored more than 50 scientific publications in the peer-reviewed journals.

Professor Smith is Vice-Provost (Research & Research Infrastructure) at Monash University. Ian is an accomplished medical researcher and is recognized as a leader in his field. His research applies proteomics technologies to study the proteases involved in the generation and metabolism of peptide regulators involved in both brain and cardiovascular function has resulted in over 250 publications and many patents. Ian serves on six international editorial boards and over the years he has held office-bearing positions in a number of national and international societies and has held and continues to hold, a variety of national and international senior government and non-government advisory board/committee memberships.

Dr. Guang Song is currently an associate professor of computer science, computational biology and bioinformatics at Iowa State University. He obtained his Masters degree in Physics and PhD degree in Computer Science from Texas A&M University. He has published over 50 scientific publications. His work on mapping ligand migration pathways in dynamic proteins received the NSF CAREER award.

Massimo Stefani is full professor of Biochemistry at the University of Firenze. He has dedicated his efforts mainly to the study of biophysical and molecular biology issues of protein folding, misfolding and amyloid aggregation and the molecular mechanisms of aggregate cytotoxicity to living systems. He has published around 160 scientific papers in outstanding international journals widely cited (over 8500 total citations, HI index 41, ISI). He is a named inventor of three issued European patents. He has been Director of the Italian Research Center on the Molecular Basis of Neurodegeneration (CIMN) and member of several Italian and foreign Centres.

Nic Taylor completed his undergraduate studies and MSc at Massey University, New Zealand and in 2000 moved to The university of Western Australia to undertake his PhD. After his PhD he was awarded and European Molecular Biology Organization Long Term Fellowship to study at the Department of Plant Sciences at the University of Oxford, UK. He was recruited back to UWA in 2006 to the newly established ARC Centre of Excellence in Plant Energy Biology. Here he has applied and developed a wide range of quantitative proteomics approaches and used these in a wide range of research projects. His lab seeks gain a comprehensive understanding of how metabolites, proteins and lipids within plant cells respond to extremes of temperature and salt.

Hernán Terenzi received his Ph.D. in Biochemistry from Universidade de São Paulo, São Paulo, Brazil (1993). After postdoctoral training at the Institut Pasteur, Paris, France, he returned to Brazil to the Universidade Federal de Santa Catarina as an adjunct professor (1998) and is currently Full Professor of Biochemistry. The Terenzi laboratory studies structure/function relationships in phosphatases and also bioinorganic models of metalloenzymes. Current projects address the development of tyrosine phosphatase inhibitors and mechanisms of activity modulation, as well as the search for novel metal artificial hydrolases. He is a research fellow from the National Council for Scientific and Technological Development (CNPq).

Dr Thevis (*1973) graduated in organic chemistry and sports sciences in 1998. He earned his PhD in Biochemistry in 2001 and did post-doctoral research at the Department of Chemistry and Biochemistry of the University of California Los Angeles (UCLA) in 2002. After being a senior researcher from 2003 to 2005 he was appointed as Professor for Preventive Doping Research at the German Sport University Cologne in 2006. Mario Thevis further qualified as Forensic Chemist, acts as director of the European Monitoring Center for Emerging Doping Agents (EuMoCEDA), and is Editor-in-Chief of DRUG TESTING & ANALYSIS. Since 2014, Professor Thevis is also vice president for research at the German Sport University Cologne.

Kemin Wang received his PhD degree from Hunan University in 1987. He was a postdoctoral fellow at ETH Zurich (1989-1991), and has been a Professor at Hunan University since 1992. He is the recipient of the National Outstanding Youth Foundation of China (1998), a member of Expert Advisory Committee (2008-) and Panel Review Committee (2010-) of Department of Chemical Science in National Natural Science Foundation of China. He received the National Natural Science Award (2011), the Natural Science Award of Hunan Province (2009), and the Science and Technology Progress Award of Hunan Province (2003). His research interests mainly focus on biological/chemical information acquisition at the nanoscale and molecular level.

Dr. Young Yang obtained his MS degree in 1990 from the Advanced Institute of Science and Technology, Korea. Later, he received a Ph.D. from the same Institute in 1997. His skills and expertise are in Gene Regulation, Transcription, Transcription Factors and Alternative Splicing. He is presently serving and working as a professor at the Department of Biological Sciences, Sookmyung Women's University in Korea.

Dr. Yaoqi Zhou is a Professor and research leader at the Institute for Glycomics, Griffith University, Parkland Dr, Southport, QLD 4222, Australia. With over 150 peer reviewed publications to his credit, Professor Yaoqi Zhou is a leading research scientist in structural bioinformatics, specialized in structure and function prediction of proteins and RNA, structure-based discovery of small molecule and peptide drugs, and discrimination of disease-causing genetic variations. Dr. Zhou received his PhD in chemical physics from State University of New York at Stony Brook, USA in 1990 and conducted his postdoctoral studies at North-Carolina State University and Harvard University. He was an Assistant Professor and later Associate Professor at Department of Physiology and Biophysics, State University of New York at Buffalo, USA, from 2000 to 2006, and a full Professor at Schools of Medicine and Informatics, Indiana University, USA, from 2006 to 2013. He moved to Griffith University in 2013.

Prof. Lello Zolla is Full Professor of Molecular Biology and head of the Proteomics lab at the Tuscia University of Viterbo. During 1986-1991 he was Director of the High School of Chemistry and Clinical Biochemistry at the University of Camerino. He has coordinated many CE and national research projects, organized many international meeting (Satellite FEBS….) and more than ten Mass Spectrometry and Proteomics courses as well. He has participated in the founding and establishment of the Italian Proteomic Society and subsequently of the Italian Proteomic Association. He is in the Editorial Board of Journal of Proteomics, Current Proteomics, Open Proteomics and Frontiers in Molecolar Biosciences.

Prof. Zolla has co-authored more than 300 scientific publications and Guest editor more than 10 special issue

Professor Bi was born in Lanzhou city, China. He received his B.S. in Biochemistry from Lanzhou University and his Ph.D. in Pathogen Biology from Chinese Academy of Preventative Medicine. After postdoctoral training in Biochemistry and Molecular Biology at the National Cancer Institute, National Institutes of Health, USA, he returned to Chinese Academy of Sciences to begin his independent career as a principal investigator in 2008. He currently is a tenured full professor of Biochemistry and Molecular Biology, Cell Biology, and Genetics. He also serves as the associate dean of College of Basic Medical Sciences, Chair of Biological Sciences at Dalian Medical University.

Dr. Somchai Chutipongtanate obtained a Doctorate in Immunology from Mahidol University and fully trained in Pediatrics specialty at Ramathibodi Hospital, Thailand. His current research involves the use of proteomic technologies including 2DE-MS and DIA/SWATH-MS for better understanding of complex pathophysiology of kidney diseases and discovery of candidate biomarkers in urine and exosome biomarkers with consistent results. Dr. Chutipongtanate also works in collaborations with basic scientists and clinicians in the area of pediatric translational medicine involving cellular immunotherapy in oncology, discovery new therapeutic targets in pediatric diseases and deciphering protective effects of human breast milk by peptide-based technology.

Dr. Gülsüm Özlem Elpek has obtained MD and Ph.D. (Pathology) from the Akdeniz University Medical School, Antalaya, Turkey. She has been teaching the residents pathological aspects of gastrointestinal, liver and pancreatic diseases since 2000. Most of her teaching sessions involve macroscopic and Histopathological evaluation of surgical resections and biopsy materials. Dr. Elpek has published more than 100 peer-reviewed articles in the field of Surgical Pathology. She is a member of Turkish Society of Gastroenterology, Turkish Society of Pathology, Turkish Association for the study of the liver, and European Society of Pathology.

Currently I work as a senior researcher at Chalmers University in Sweden. My research involves analytical methods like mass spectrometry and chromatography and is focused on compounds generated by the photosynthetic process in plants. From 2014 - 2018 I trained as a postdoctoral scholar at the VU University in Amsterdam. From 2011 to 2014 I worked as a postdoctoral fellow at the University of California in Los Angeles, US. I obtained my PhD degree in 2011 from Linkoping University in biochemistry with a focus on proteomics and mass spectrometry methods.

Dr. Giri did his PhD from Sapenza University of Rome, Italy and later postdoc from McMaster University. Dr Giri works on Intrinsically Disordered Proteins and the folding perspectives. He also works on Zika virus, Chikungunya virus and other emerging infectious diseases.

Dr. Fei Guo is an Associate Professor in the School of Computer Science and Technology, Tianjin University. She received the B.S. degree and the Ph.D. degree from Shandong University, in 2007 and 2012, respectively. She was a Postdoctoral Fellow at City University of Hong Kong between 2012 and 2013. Her research is in the areas of bioinformatics, computational biology, machine learning, and proteomics. She has published more than 40 SCI papers. Several related works have been published by Bioinformatics, Journal of Chemical Information and Modeling, RECOMB2013, ISMB2014, etc.

Dr. Nayak is an Associate Professor in Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Lovely Professional University (LPU), India. He is also a member of review panel for research project proposals of SERB (DST, GoI) and panel member of Department Doctoral Board for Chemistry (LPU) and reviewer of various scientific journals. He has more than 13 years of experience in research and teaching (Medicinal Chemistry) aimed at identification of novel molecular probes for protein interaction study. He has published and presented more than 60 papers and has supervised more than 20 scientific projects for UG and PG students.

I received my Ph.D. in Molecular Genetics in 2014, and my postdoctoral degree in Pharmaceutical Biotechnology from Pharmaceutical Sciences Research, Shiraz University of Medical Sciences in 2017. Presently, I have published more than 40 papers in the fields of vaccine design, and protein engineering. My fields of interest are industrial biotechnology, bioinformatics, systems biology, and immunoinformatics.

Dr. Sun is an associate professor of Core Instrument Facility, Institute of Basic Medical Sciences, Peking Union Medical College. He is responsible for mass spectrometry section in Core Instrument Facility. His group focuses on the biomarker discovery from body fluid proteomics, including urine, serum, saliva etc.They used various proteomic techniques to large-scale proteomic analysis, including labeled methods, iTRAQ and TMT, and label-free methods, DIA and SWATH.They also develop new methods for the applications of proteomic techniques to clinical diseases.

Dr. Tang received his M.D. from Chongqing Medical University, and Ph.D. from Chongqing University. Currently, he is the director of the Digestive Cancer Center of The First Affiliated Hospital, Wenzhou Medical University. He investigated and explored that Dicer, a key enzyme in the RNAi pathway, is essential for genome stability. The goal of Tang laboratory is to understand the role of Dicer in DNA damage, inflammation and cancer.

Dr. Liangliang Xu obtained his PhD Degree from the department of orthopaedics and traumatology, the Chinese University of Hong Kong in 2012. In the last ten years, his focus was on the basic and applied study of mesenchymal stem cells, and emphasized studying the basic factors and related signaling pathways that regulate proliferation, apoptosis and differentiation of mesenchymal stem cells. In the year 2016, he joined in Guangzhou University of Chinese Medicine as a Professor. Overall, Dr. Xu has published 38 SCI papers, including 15 papers as the first author and corresponding author.

Dr. Tao Zhou obtained his doctoral degree in reproductive medicine from Nanjing Medical University in 2014. Recent years, he mainly participated in the study of male reproduction using various proteomic strategies, and was in charge of proteomic data analysis and database construction. Currently, he presided over several scientific research projects at both the national and provincial levels, which were aimed to develop next-generation proteomic softwares and as well as to bring proteomics from bench to bedside for better diagnosis of male infertility and cancers.